BRPI0917160A2 - método para concentrar biopolímeros sensíveis ao cisalhamento - Google Patents

método para concentrar biopolímeros sensíveis ao cisalhamento

Info

Publication number
BRPI0917160A2
BRPI0917160A2 BRPI0917160A BRPI0917160A BRPI0917160A2 BR PI0917160 A2 BRPI0917160 A2 BR PI0917160A2 BR PI0917160 A BRPI0917160 A BR PI0917160A BR PI0917160 A BRPI0917160 A BR PI0917160A BR PI0917160 A2 BRPI0917160 A2 BR PI0917160A2
Authority
BR
Brazil
Prior art keywords
shear sensitive
sensitive biopolymers
concentrating shear
concentrating
biopolymers
Prior art date
Application number
BRPI0917160A
Other languages
English (en)
Inventor
Artur Mitterer
Christa Mayer
Meinhard Hasslacher
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of BRPI0917160A2 publication Critical patent/BRPI0917160A2/pt
Publication of BRPI0917160B1 publication Critical patent/BRPI0917160B1/pt
Publication of BRPI0917160B8 publication Critical patent/BRPI0917160B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/24—Dialysis ; Membrane extraction
    • B01D61/243—Dialysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02—Hollow fibre modules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/16—Flow or flux control
    • B01D2311/165—Cross-flow velocity control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2325/00—Details relating to properties of membranes
    • B01D2325/04—Characteristic thickness

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0917160A 2008-08-28 2009-08-27 método para concentrar biopolímeros sensíveis ao cisalhamento BRPI0917160B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19045308P 2008-08-28 2008-08-28
US61/190453 2008-08-28
PCT/US2009/055227 WO2010025278A1 (en) 2008-08-28 2009-08-27 Method of concentrating shear-sensitive biopolymers using hollow fibre membranes

Publications (3)

Publication Number Publication Date
BRPI0917160A2 true BRPI0917160A2 (pt) 2015-11-17
BRPI0917160B1 BRPI0917160B1 (pt) 2020-01-07
BRPI0917160B8 BRPI0917160B8 (pt) 2021-07-27

Family

ID=41314703

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917160A BRPI0917160B8 (pt) 2008-08-28 2009-08-27 método para concentrar biopolímeros sensíveis ao cisalhamento

Country Status (13)

Country Link
US (1) US8388847B2 (pt)
EP (2) EP3693081A1 (pt)
JP (2) JP2014210814A (pt)
KR (1) KR101376410B1 (pt)
CN (1) CN102137708B (pt)
AR (1) AR073220A1 (pt)
AU (1) AU2009285736B2 (pt)
BR (1) BRPI0917160B8 (pt)
CA (1) CA2732790C (pt)
MX (1) MX2011002193A (pt)
NZ (1) NZ591596A (pt)
TW (1) TWI469992B (pt)
WO (1) WO2010025278A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013101741A1 (en) 2011-12-30 2013-07-04 Abbott Molecular, Inc. Channels with cross-sectional thermal gradients
CN105705516B (zh) 2013-11-08 2019-11-01 杰特有限公司 浓缩von Willebrand因子或其络合物的方法
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
PL3158055T3 (pl) 2014-06-13 2020-03-31 Csl Limited Ulepszone wytwarzanie rekombinowanego czynnika von Willebranda w bioreaktorze
WO2019129974A1 (fr) 2017-12-28 2019-07-04 I-Sep Système et procédé de traitement de liquide hémorragique pour de l'autotransfusion
US11241656B2 (en) 2018-11-29 2022-02-08 Watersep Bioseparations Llc Single pass cross flow diafiltration module and method
CN112023713B (zh) * 2020-07-21 2021-07-06 东华大学 一种吸附和降解微塑料的双功能碳纤维膜及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61113458A (ja) * 1984-11-09 1986-05-31 住友ベークライト株式会社 血液浄化器
JPH05168705A (ja) 1991-06-11 1993-07-02 Toray Ind Inc フォンウィルブランド因子を除去するシステム
US5211850A (en) * 1991-07-26 1993-05-18 Research Medical, Inc. Plasma filter sorbent system for removal of components from blood
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
JP2003505077A (ja) * 1999-07-23 2003-02-12 ジェネンテック・インコーポレーテッド 平行流ろ過法を用いるｒｎａｓｅ−及び有機溶媒−非含有プラスミドｄｎａの精製方法
DK1206961T3 (da) * 1999-08-20 2007-04-02 Asahi Kasei Medical Co Ltd Filtermembraner til fysiologisk aktive stoffer
DE60313818T2 (de) * 2002-03-14 2007-10-31 Nipro Corp., Osaka Dialysator und Verfahren zu dessen Herstellung
CN101269298B (zh) 2007-03-23 2011-06-01 中国科学院过程工程研究所 利用浓差极化浓缩生物大分子的膜过滤方法及其装置
NZ586316A (en) * 2007-12-28 2012-06-29 Baxter Int Counter-pressure filtration of proteins

Also Published As

Publication number Publication date
JP5933265B2 (ja) 2016-06-08
KR101376410B1 (ko) 2014-03-20
JP2017066146A (ja) 2017-04-06
JP2012501339A (ja) 2012-01-19
NZ591596A (en) 2012-07-27
KR20110058848A (ko) 2011-06-01
US20100051550A1 (en) 2010-03-04
MX2011002193A (es) 2011-04-11
US8388847B2 (en) 2013-03-05
WO2010025278A1 (en) 2010-03-04
TW201016720A (en) 2010-05-01
EP3693081A1 (en) 2020-08-12
JP2014210814A (ja) 2014-11-13
BRPI0917160B1 (pt) 2020-01-07
BRPI0917160B8 (pt) 2021-07-27
AU2009285736A1 (en) 2010-03-04
CN102137708A (zh) 2011-07-27
TWI469992B (zh) 2015-01-21
AU2009285736B2 (en) 2013-09-19
CN102137708B (zh) 2014-07-09
AR073220A1 (es) 2010-10-20
CA2732790C (en) 2018-12-04
CA2732790A1 (en) 2010-03-04
EP2334411A1 (en) 2011-06-22

Similar Documents

Publication Publication Date Title
BRPI0913145A2 (pt) método para identificar automaticamente malware e sistema para identificar automaticamente malware
BRPI0907279A2 (pt) sistema de monitoramento fetal e método para o monitoramento fetal.
BRPI0915309A2 (pt) método e sistema para mineração de solução
BRPI0916450A2 (pt) método, e sistema
BRPI0911758A2 (pt) anticorpos para receptor de produtos finais de glicação avançada (rage) e utilizações dos mesmos
BR112012010469A2 (pt) adesivo estrutural e metodo para aplicar adesivo estrutural
BRPI0811415A2 (pt) sistema e método para wikificar conteúdo para navegação de conhecimento e descoberta
BRPI1016218A2 (pt) sistema, e, método
BRPI1013630A2 (pt) sistema, e método
BRPI0915845A2 (pt) sistema para medição de tensão de cizalhamento em tubulares fundo de poço
BRPI1014894A2 (pt) método, e sistema
BR112012010299A2 (pt) método implementado por computador, e, sistema para a realização de um método de caracterização
BRPI0814085A2 (pt) Sistema, e, método
BRPI0907354A2 (pt) sistema de livro responsivo e método para usar livro responsivo
BRPI0815101A2 (pt) Método, e, sistema
BRPI0820253A2 (pt) Sistema de sensoriamento, e, método para sensoriar uma mudança em uma propriedade de um material
BRPI0811722A2 (pt) Método, e sistema
BRPI0822393A2 (pt) Processo e sistema para envolver cargas
BRPI0913074A2 (pt) pneumático e método para sua fabricação
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BRPI0924215A2 (pt) método e sistema para execução de medição
BRPI0917782A2 (pt) sistema e método
BRPI0810963A2 (pt) sistema, e, método
BRPI0815550A2 (pt) Método para estabilizar fenilefrina
BRPI0919749A2 (pt) método para embalagem de cigarro e sistema de embalagem de cigarro

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAXALTA GMBH (CH) , BAXALTA INCORPORATED (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]

Free format text: O DEPOSITANTE DEVE RESPONDER A EXIGENCIA FORMULADA NESTE PARECER POR MEIO DO SERVICO DE CODIGO 206 EM ATE 60 (SESSENTA) DIAS, A PARTIR DA DATA DE PUBLICACAO NA RPI, SOB PENA DO ARQUIVAMENTO DO PEDIDO, DE ACORDO COM O ART. 34 DA LPI.PUBLIQUE-SE A EXIGENCIA (6.20).

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/01/2020, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/08/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO